glp 1 drugs definition America's Poison Centers Mapping the effectiveness and risks
Description
These are presented as individual reports and not as typical outcomes
DPP-4 Inhibitors: Impact on glycemic control and cardiovascular risk factors
T., Odden, M
Clinical trials have reported gastrointestinal side effects as common adverse events with incretin-based therapies, including nausea and vomiting, which may affect patient adherence
Payers arent necessarily incentivized to invest in the longer-term cost savings found in industry-funded models
